Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""THERAPEUTIC use of monoclonal antibodies"" wg kryterium: Temat


Tytuł:
Clinical Outcome of Nivolumab Plus Ipilimumab in Patients with Locally Advanced Non-Small-Cell Lung Cancer with Relapse after Concurrent Chemoradiotherapy followed by Durvalumab.
Autorzy:
Mouri, Atsuto (AUTHOR)
Watanabe, Satoshi (AUTHOR)
Tokito, Takaaki (AUTHOR)
Nagai, Yoshiaki (AUTHOR)
Saida, Yu (AUTHOR)
Imai, Hisao (AUTHOR)
Yamaguchi, Ou (AUTHOR)
Kobayashi, Kunihiko (AUTHOR)
Kaira, Kyoichi (AUTHOR)
Kagamu, Hiroshi (AUTHOR)
Pokaż więcej
Źródło:
Cancers. Apr2024, Vol. 16 Issue 7, p1409. 11p.
Czasopismo naukowe
Tytuł:
Intracranial Efficacy of Atezolizumab, Bevacizumab, Carboplatin, and Paclitaxel in Real-World Patients with Non-Small-Cell Lung Cancer and EGFR or ALK Alterations.
Autorzy:
Rathbone, Marcus (AUTHOR)
O'Hagan, Conor (AUTHOR)
Wong, Helen (AUTHOR)
Khan, Adeel (AUTHOR)
Cook, Timothy (AUTHOR)
Rose, Sarah (AUTHOR)
Heseltine, Jonathan (AUTHOR)
Escriu, Carles (AUTHOR)
Pokaż więcej
Źródło:
Cancers. Apr2024, Vol. 16 Issue 7, p1249. 18p.
Czasopismo naukowe
Tytuł:
Benefits of camrelizumab plus carboplatin and albumin paclitaxel as induction therapy for locally advanced borderline resectable or unresectable esophageal squamous cell carcinoma.
Autorzy:
Chao, Li (AUTHOR)
Liu, Jianting (AUTHOR)
Chen, Yun (AUTHOR)
Fan, Yuhui (AUTHOR)
Guo, Shiping (AUTHOR)
Zhang, Shuangping (AUTHOR)
Pokaż więcej
Źródło:
Thoracic Cancer. Mar2024, Vol. 15 Issue 8, p622-629. 8p.
Czasopismo naukowe
Tytuł:
Cost-effectiveness and budget impact analysis of Daratumumab, Lenalidomide and dexamethasone for relapsed-refractory multiple myeloma.
Autorzy:
Goudarzi, Zahra (AUTHOR)
Shahtaheri, Rahil Sadat (AUTHOR)
Najafpour, Zhila (AUTHOR)
Hamedifar, Haleh (AUTHOR)
Ebrahimi, Hamidreza (AUTHOR)
Pokaż więcej
Źródło:
Cost Effectiveness & Resource Allocation. 2/28/2024, Vol. 22 Issue 1, p1-10. 10p.
Czasopismo naukowe
Tytuł:
First effectiveness data of lenvatinib and pembrolizumab as first-line therapy in advanced anaplastic thyroid cancer: a retrospective cohort study.
Autorzy:
Soll, Dominik
Bischoff, Philip
Frisch, Anne
Jensen, Marie
Karadeniz, Zehra
Mogl, Martina T.
Horst, David
Penzkofer, Tobias
Spranger, Joachim
Keilholz, Ulrich
Mai, Knut
Pokaż więcej
Źródło:
BMC Endocrine Disorders. 2/22/2024, Vol. 24 Issue 1, p1-9. 9p.
Czasopismo naukowe
Tytuł:
New Frontiers in Monoclonal Antibodies for Relapsed/Refractory Diffuse Large B-Cell Lymphoma.
Autorzy:
Schipani, Mattia (AUTHOR)
Rivolta, Giulia Maria (AUTHOR)
Margiotta-Casaluci, Gloria (AUTHOR)
Mahmoud, Abdurraouf Mokhtar (AUTHOR)
Al Essa, Wael (AUTHOR)
Gaidano, Gianluca (AUTHOR)
Bruna, Riccardo (AUTHOR)
Pokaż więcej
Źródło:
Cancers. Jan2024, Vol. 16 Issue 1, p187. 18p.
Czasopismo naukowe
Tytuł:
Efficacy and Safety of Liver Chemoembolization Procedures, Combined with FOLFIRI Chemotherapy, in First-Line Treatment of Metastatic Colorectal Cancer in Patients with Oncogene Mutations.
Autorzy:
Szemitko, Marcin (AUTHOR)
Falkowski, Aleksander (AUTHOR)
Modrzejewska, Monika (AUTHOR)
Golubinska-Szemitko, Elzbieta (AUTHOR)
Pokaż więcej
Źródło:
Cancers. Jan2024, Vol. 16 Issue 1, p71. 10p.
Czasopismo naukowe
Tytuł:
Improved Drug-Response Prediction Model of APC Mutant Colon Cancer Patient-Derived Organoids for Precision Medicine.
Autorzy:
Shin, Yong Jae (AUTHOR)
Jo, Eun Hae (AUTHOR)
Oh, Yunjeong (AUTHOR)
Kim, Da Som (AUTHOR)
Hyun, Seungyoon (AUTHOR)
Yu, Ahran (AUTHOR)
Hong, Hye Kyung (AUTHOR)
Cho, Yong Beom (AUTHOR)
Pokaż więcej
Źródło:
Cancers. Dec2023, Vol. 15 Issue 23, p5531. 19p.
Czasopismo naukowe
Tytuł:
Efficacy and Safety of Daratumumab, Pomalidomide, and Dexamethasone (DPd) Compared to Daratumumab, Bortezomib, and Dexamethasone (DVd) in Daratumumab–Naïve Relapsed Multiple Myeloma.
Autorzy:
Afrough, Aimaz (AUTHOR)
Atrash, Shebli (AUTHOR)
Paul, Barry (AUTHOR)
Ouchveridze, Evguenia (AUTHOR)
Ahmed, Nausheen (AUTHOR)
Mahmoudjafari, Zahra (AUTHOR)
Bashir, Anam (AUTHOR)
Alkharabsheh, Omar (AUTHOR)
Hashmi, Hamza (AUTHOR)
Abdallah, Al-Ola (AUTHOR)
Pokaż więcej
Źródło:
Cancers. Oct2023, Vol. 15 Issue 19, p4894. 13p.
Czasopismo naukowe
Tytuł:
Randomized Phase 2 Clinical Trial of Olaratumab in Combination with Gemcitabine and Docetaxel in Advanced Soft Tissue Sarcomas.
Autorzy:
Attia, Steven (AUTHOR)
Villalobos, Victor (AUTHOR)
Hindi, Nadia (AUTHOR)
Wagner, Andrew J. (AUTHOR)
Chmielowski, Bartosz (AUTHOR)
Oakley III, Gerard J. (AUTHOR)
Peterson, Patrick M. (AUTHOR)
Ceccarelli, Matteo (AUTHOR)
Jones, Robin L. (AUTHOR)
Dickson, Mark A. (AUTHOR)
Pokaż więcej
Źródło:
Cancers. Oct2023, Vol. 15 Issue 19, p4871. 15p.
Czasopismo naukowe
Tytuł:
Bilobar Radioembolization Carries the Risk of Radioembolization-Induced Liver Disease in the Treatment of Advanced Hepatocellular Carcinoma: Safety and Efficacy Comparison to Systemic Therapy with Atezolizumab/Bevacizumab.
Autorzy:
Jeschke, Matthias (AUTHOR)
Ludwig, Johannes M. (AUTHOR)
Leyh, Catherine (AUTHOR)
Pabst, Kim M. (AUTHOR)
Weber, Manuel (AUTHOR)
Theysohn, Jens M. (AUTHOR)
Lange, Christian M. (AUTHOR)
Herrmann, Ken (AUTHOR)
Schmidt, Hartmut H. -J. (AUTHOR)
Jochheim, Leonie S. (AUTHOR)
Pokaż więcej
Źródło:
Cancers. Sep2023, Vol. 15 Issue 17, p4274. 13p.
Czasopismo naukowe
Tytuł:
A Phase II Clinical Trial of Pembrolizumab Efficacy and Safety in Advanced Renal Medullary Carcinoma.
Autorzy:
Nze, Chijioke (AUTHOR)
Msaouel, Pavlos (AUTHOR)
Derbala, Mohamed H. (AUTHOR)
Stephen, Bettzy (AUTHOR)
Abonofal, Abdulrahman (AUTHOR)
Meric-Bernstam, Funda (AUTHOR)
Tannir, Nizar M. (AUTHOR)
Naing, Aung (AUTHOR)
Pokaż więcej
Źródło:
Cancers. Aug2023, Vol. 15 Issue 15, p3806. 11p.
Czasopismo naukowe
Tytuł:
Efficacy of the Combination of Systemic Sequential Therapy and Locoregional Therapy in the Long-Term Survival of Patients with BCLC Stage C Hepatocellular Carcinoma.
Autorzy:
Kawamura, Yusuke (AUTHOR)
Akuta, Norio (AUTHOR)
Shindoh, Junichi (AUTHOR)
Matsumura, Masaru (AUTHOR)
Okubo, Satoshi (AUTHOR)
Tominaga, Licht (AUTHOR)
Fujiyama, Shunichiro (AUTHOR)
Hosaka, Tetsuya (AUTHOR)
Saitoh, Satoshi (AUTHOR)
Sezaki, Hitomi (AUTHOR)
Suzuki, Fumitaka (AUTHOR)
Suzuki, Yoshiyuki (AUTHOR)
Ikeda, Kenji (AUTHOR)
Arase, Yasuji (AUTHOR)
Hashimoto, Masaji (AUTHOR)
Kozuka, Takuyo (AUTHOR)
Kumada, Hiromitsu (AUTHOR)
Pokaż więcej
Źródło:
Cancers. Aug2023, Vol. 15 Issue 15, p3789. 16p.
Czasopismo naukowe
Tytuł:
Combination Therapy with a Bispecific Antibody Targeting the hERG1/β1 Integrin Complex and Gemcitabine in Pancreatic Ductal Adenocarcinoma.
Autorzy:
Lottini, Tiziano (AUTHOR)
Duranti, Claudia (AUTHOR)
Iorio, Jessica (AUTHOR)
Martinelli, Michele (AUTHOR)
Colasurdo, Rossella (AUTHOR)
D'Alessandro, Franco Nicolás (AUTHOR)
Buonamici, Matteo (AUTHOR)
Coppola, Stefano (AUTHOR)
Devescovi, Valentina (AUTHOR)
La Vaccara, Vincenzo (AUTHOR)
Coppola, Alessandro (AUTHOR)
Coppola, Roberto (AUTHOR)
Lastraioli, Elena (AUTHOR)
Arcangeli, Annarosa (AUTHOR)
Pokaż więcej
Źródło:
Cancers. Apr2023, Vol. 15 Issue 7, p2013. 19p.
Czasopismo naukowe
Tytuł:
Target Antigen Attributes and Their Contributions to Clinically Approved Antibody-Drug Conjugates (ADCs) in Haematopoietic and Solid Cancers.
Autorzy:
Esapa, Benjamina (AUTHOR)
Jiang, Jiexuan (AUTHOR)
Cheung, Anthony (AUTHOR)
Chenoweth, Alicia (AUTHOR)
Thurston, David E. (AUTHOR)
Karagiannis, Sophia N. (AUTHOR)
Pokaż więcej
Źródło:
Cancers. Mar2023, Vol. 15 Issue 6, p1845. 37p.
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies